Obesity is a proven risk factor for neurodegenerative disease like Alzheimer's disease (AD). Accumulating evidences suggested that nutritional interventions provide potential for prevention and treatment of AD. The present study aimed to investigate the effect of dietary treatment of obese rats with natural Raspberry ketone (RK) and their relationship with neurodegeneration. Obesity was first induced in 40 male Wistar rats (140 -160g) by feeding high fat diet (HFD) for 16 weeks. Obese rats were then assigned into 4 groups (n= 10 each).
Introduction:
The prevalence of obesity has significantly increased during the last decades reaching epidemic proportions in many countries (Valdecantos et al., 2009 ). Obesity results from the excessive accumulation of fat and its risk is not confined to adults; it extends also to children and adolescents
(Knopp et al., 2008; Prokesch et al., 2009).
Obesity is a multifactorial abnormality that has genetic and environmental bases. Changes in the environment interact with the other factors in a lethal combination. The genetic background loads the gun, but the environment pulls the trigger (Bray, 2004; Candib, 2007) .
Complications of obesity:
Obesity, particularly abdominal obesity, has many complications such as dyslipidemia, atherosclerosis and type 2 diabetes mellitus (T2DM). Abdominal obesity is a major cause of cardiovascular disease (CVD) morbidity and mortality ( 
1-Dyslipidemia :
Obesity is a known complication of obesity (Sowers, 2003) . Obese children and adults, particularly those with a central or abdominal distribution of fat, have elevated concentrations of serum triacylglycerol (TAG), a surrogate measure of very low density lipoprotein cholesterol (VLDL-C) and low concentrations of high density lipoprotein cholesterol (HDL-C) (Abate, 1999; Freedman et al., 2002) . Obesity is also associated with higher levels of total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) (Knopp et al., 2008).
2-Oxidative stress :
Obesity may be a state of chronic oxidative stress. It enhances oxidative stress in young and old population as shown by elevations in lipid peroxidation, or protein oxidation. Lipid peroxidation is associated with several indices of adiposity and a low systemic antioxidant defense (i.e. antioxidant enzymes, glutathione "GSH"). Oxidative stress is related to chronic disease and is one of the mechanisms underlying the development of co-morbidities ( 
3-Inflammation :
In the liver and adipose tissues obesity promotes a state of chronic low-grade inflammation 
4-Insulin resistance, hyperinsulinemia and hyperglycemia:
Insulin resistance (IR) hyperinsulinemia and hyperglycemia are linked with obesity (Sowers, 2003) . Insulin resistance, which can be defined as a diminished ability of the cell to respond to the action of insulin, is the most important pathophysiological feature in many prediabetic states and is the first detectable defect in T2DM. Although the classic features of acute inflammation are absent, signs of chronic inflammation are observed with the release of inflammatory cytokines including TNF-α, IL-6 and IL-1β. These cytokines have been implicated in the pathogenesis of IR (Hotamisligil, 2006; Shoelson et al., 2007) . Obesity-associated adipocyte apoptosis (cell death) appears to be the primary event underlying insulin insensitivity. The subsequent infiltration of macrophages and release of reactive oxygen species (ROS) play an important role in cytokine-related IR ( The intracellular mediators of this inflammatory response include nuclear factor kappa B (NFkB), c-Jun amino-terminal kinase-stress-activated protein kinase, and induction of the suppressor of cytokine signaling-3 (Kahn et al., 2006). Macrophage infiltration occurs not only in the adipocyte, but also in the liver. The associated activation of the c-Jun amino-terminal kinasestress-activated protein kinase pathway also promotes the development of hepatic inflammation leading to hepatic steatosis (fat deposition), lipid peroxidation and hepatic As shown in Figure ( 2), obesity leads to an inflammatory response in the liver and in adipose tissues. Obesity-induced inflammation results in infiltration of macrophages and release of cytokines, TNF-α, IL-6 and IL-1β. The downstream effector of cytokine-induced inflammation is induction of inducible nitric oxide synthase (iNOS). The extremely high levels of nitric oxide (NO) that are released, together with reactive oxygen species, generate reactive nitrogen species including peroxynitrite, which leads to S-nitrosylation and tyrosine nitration (posttranslational modifications) of proteins which alters the function of many proteins, including those involved in insulin signaling.
5-Type 2 diabetes :
A 
Insulin in the brain :
Glucose uptake by the brain and across the central nervous system and the blood brain barrier (BBB) takes place by saturable facilitated diffusion system. This occurs via an insulin independent manner through non-insulin sensitive glucose transporters; GLUT-1, GLUT-3, and GLUT-5 found in astrocytes, neurons and microglia, respectively. Hence, the brain was previously considered an insulin insensitive organ. However, several insulin sensitive glucose transporters as GLUT-2, GLUT-4 and GLUT-8 and insulin receptors (IRs) were found in the brain, which provide evidence that insulin must have other actions in the brain (Banks et al., 2012). One of the first recognized central insulin actions was its anorexic effect and its ability to reduce body weight gain through facilitating brain energy supply. It increases adenosine triphosphate (ATP) and consequently close ATPsensitive K + channels which in-turn reduce food intake. Additionally, insulin exerts its action by regulating neuronal activity in the hypothalamus and deactivating appetite centres 
Targets of AKT include :
1-AKT substrate of 160 kDa (AS160) : once phosphorylated by AKT it is activated and causes translocation of the glucose transporter GLUT-4 to the plasma membrane (Takei and Nawa, 2014).
2-Mammalian target of rapamycin complex 1 (mTORC1) mediated protein : which has beneficial role in synaptic activity, dendritic growth of neurons, axon elongation and neuronal synaptic repair. However, its dysregulation causes detrimental effects including neurodegenerative diseases and neuronal cell death due to disrupted mTORC1-dependent autophagy, a major mechanism to degrade misfolded proteins and damaged organelles in neurons (Takei and Nawa, 2014).
3-Glycogen synthase kinase 3 (GSK3) : a serine/threonine kinase that regulates glycogen synthesis and controls multiple cell signaling pathways.
Its activation, however, can phosphorylate tau protein, a process involved in the pathogenesis of AD. AKT interferes the latter process via inactivating GSK3β (Kleinridders et al., 2014).
4-Fork head transcription factors (FOXOs) :
where the activation of AKT promotes the phosphorylation and the inhibition of FOXO and hence protects the brain against apoptosis induced by apoptosis-stimulating fragment ligand (FasL) promoter and Bcl-2 interacting mediator of death (Bim); the targets of FOXO (Bassil et al., 2014).
The second major insulin/IGF signaling pathway (Fig. 4) 
Defective insulin signaling in the brain :
Defective insulin signaling in the brain contributes at the cellular level to the aggregation and deposition of Aβ plaques, hyperphosphorylation of tau, promotion of neuroinflammation, disruption of synaptic plasticity and oxidative stress. These in turn cause impairment of memory and cognition (Craft et al., 2013). In other words, a neurodegenerative disorder in which defect in brain insulin signaling and consequently glucose metabolism lead to AD pathogenesis. Therefore, AD has been proposed as type 3 diabetes (Leszek et al., 2017).
1-Amyloid plaques :
The Aβ plaques is one of the major hallmarks found in the brain of AD patients. These plaques are composed mainly of pathologically aggregated Aβ peptides, predominantly Aβ 40 and Aβ 42 derived from a larger molecule; APP. Normally, APP is cleaved within its extracellular domain to produce soluble APP alpha fragment by a protease known as α-secretase. On the contrary, in AD, proteolysis occurs by the sequential enzymatic actions of β-secretase, namely, BACE-1 to form APP beta. The carboxy terminal fragments (CTF) generated by α-and β-secretase are called (CTF83 and CTF99, 
2-Hyperphosphorylation of Tau :
Tau, is a microtubule associated protein, first discovered by Murray Weingarten, Marc Kirschner and their colleagues as a factor that was associated with tubulin promoting stabilization of axonal microtubules (Weingarten et al., 1975) . Tau undergoes several post-translational modifications, including: O-GlcNAclation, phosphorylation, glycation, glycosylation, sumoylation and cleavage. O-GlcNAcylation is a dynamic modification involving the attachment of Nacetyl-D-glucosamine (GlcNAc) moieties to the hydroxyl group of serine and threonine residues. Tau phosphorylation and dephosphorylation is mediated by several kinases and phosphatases including GSK3β, CDK5, MAPK and protein phosphatase 2A (PP-2A) (Kim and Feldman, 2015).
Insulin resistance in the brain can induce different pathological tau modification (Fig. 7) (de la Monte, 2012) including tau hyperphos- phorylation through preventing the stimulation of PI3K-AKT signaling resulting in GSK3β activation or dysregulation O-GlcNAcylation. Consequently, hyperphosphorylated tau misfolds and selfaggregates into insoluble fibrillar tangles of paired helical filaments and straight filaments. These disrupt microtubule organization and form NFT, dystrophic neuritis, and neuropil threads. In other words, the accumulation of fibrillar tau disrupts neuronal cytoskeletal networks and axonal transport, leading to synaptic disconnection and neurodegeneration (Iqbal et al., 2009). Furthermore, prefibrillar tau can aggregate into soluble neurotoxic oligomers that cause synaptic disconnection and neuronal death (Takashima, 2010).
3-Neuroinflammation :
One of the consequences of disrupted brain insulin signaling is a well defined state of neuroinflammation, represented by increased inflammatory cytokines, TNF-α, and cyclooxygenase-2 and decreased interleukin-10, as well as activated nuclear factor-kappB (NFκB) pathway, which further activates amyloid pathology. The aforementioned inflammatory state is a result of defect in IR/IRS-1/ AKT/GSK-3α/β signaling pathway and decreased IDE (Aβ-insulin degrading protease), that results in amyloid plaque formation. The formed amyloid peptides activates microglia and astrocytes by 
4-Disruption of synaptic plasticity and transmission :
Defective insulin signaling contributes to deficit in neuro-plasticity, namely, decreased neuronal spine density, decreased synaptic transmission and increased oxidative stress ( 
5-Oxidative stress and advanced glycation end products :
Disrupted insulin signaling leads to mitochondrial dysfunction and consequently a well-defined state of oxidative stress. The latter involves the production of reactive oxygen species (ROS) and reactive nitrogen species, such as superoxide anion, hydrogen peroxide (H 2 O 2 ), hydroxyl radical, nitric oxide, and the related peroxynitrite, as well as, lipid peroxidation. Eventually, oxidative damage is associated with the pathophysiology of many diseases through inducing severe damage to cell membranes, and breakdown of deoxyribonucleic acid (DNA) and protein structures. It can also develop a state of chronic inflammation and cause cell apoptosis through modulating the activity of some transcriptional factors as NF-κB. As a result of these changes in the brain, cerebral glucose metabolism is reduced leading to reduced ATP synthesis, contributing to disruption of neuronal functioning, loss of synapses, and overall neurodegeneration ( Additionally, the over production of ROS results in the glycation of proteins and the production of advanced glycation end products (AGEs), that have pro-oxidant effect. Receptor for advanced Alzheimer's disease is characterized by decline in at least two of four essential cognitive functions : (1) memory; (2) ability to speak or understand language; (3) capacity to plan, make sound judgements, and carry out complex tasks and (4) ability to process and interpret visual information. The decline may be severe enough to interfere with day-to-day life ( There are several links between obesity and AD such as oxidative stress, inflammation and the other complications of obesity like dyslipidemia, insulin resistance, diabetes, hypertension, metabolic syndrome, heart disease and cerebrovascular disease (Fig. 9) . This association may reflect a direct effect of hyperglycemia, hyperinsulinemia, and diabetes-related comorbidities such as hypertension and dyslipidemia on brain degenerative changes (Fig. 10) (Biessels et al.,  2006; Korf et al., 2006 ). Furthermore; cardiovascular disease was found to be associated with increased risk of AD, especially in people with peripheral arterial disease, suggesting that extensive peripheral atherosclerosis is a risk factor for AD (Hofman et al., 2006) . Purandare et al. (2006) added that cerebrovascular disease, stroke and spontaneous cerebral emboli were related to a higher risk of AD. Increased obesity causes IR and hyperinsulinemia. Insulin levels may decrease over time due to pancreatic failure, resulting in glucose intolerance and diabetes. Obesity hyperinsulinemia, glucose intolerance and diabetes could increase brain Aβ deposition leading to AD individually or in aggregate in addition to causing cerebrovascular disease. Several studies have found that high physical activity is associated with low adiposity, lower hyperinsulinemia, and is inversely related to AD risk (Larson et al., 2006) . Type 2 diabetes is nowadays strongly associated with AD to the extent that AD is termed type 3 diabetes. Understanding all the key players in AD neuropathogenesis will help identify possible therapeutic targets. Several hypotheses were proposed to explain AD pathogenesis on a molecular level (Wen et al., 2017).
1-Cholinergic hypothesis :
The earliest hypothesis explaining AD pathogenesis focused on cholinergic system, the major neurotransmitter system involved in learning and memory, and its deficit in early AD stages through loss of cholinergic neurons, reduced choline uptake and decreased Ach release (Contestabile, 2011).
The relation between cholinergic hypofunction and AD can be manifested in several forms. 
3-Tau hypothesis :
The second major neuropathological feature that develops with the progression of AD is the accumulation of NFT. This processes starts with abnormal hyperphosphorylation of tau that sequesters normal tau, and the two major neuronal microtubule-associated protein (MAP1 and MAP2). This consequently disrupts microtubules and promotes self-assembly into tangles of paired helical and or straight filaments. GSK-3β and CDK5, two major kinases, are involved in hyperphosphorylation of tau are up-regulated in AD. However, PP-2A, the major phosphatase enzyme that regulate the phosphorylation of tau, is down-regulated. Therefore, one attractive approach in the treatment of AD could be targeting these enzymes by inhibition of GSK-3β activity and modulation of PP-2A. Lithium chloride, is prescribed as a GSK-3β inhibitor (Iqbal and  Grundke Therefore, the aim of this study was to clarify the effect of RK with calorie restricted diet in obesity induced Alzheimer disease namely modulation of molecular pathway in oxidative stress, dyslipidemia, amyloid beta-peptide (AB) extracellular plaques formation and cholinergic activity using orlistate as reference antiobese drug.
Conclusion:
CR diet administration with RK effectively modulated the neurodegenerative changes induced by obesity to greater extend than its administration with orlistate due to antioxidant effect of RK. This was reflected on BACE-1 expression and subsequently the accumulation of Aβ plaques which is the hallmark of AD. So this study supports the recent evidence suggesting the potential of RK supplement with CR diet as an effective intervention for prevention and treatment of AD. 
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